Biofrontera Inc. Board Representation and Ownership Disclosure

Biofrontera AG has entered into an agreement with Biofrontera Inc. that allows Biofrontera AG to appoint a representative to the board of directors of Biofrontera Inc. Dr. Heikki Lanckriet has been appointed as the representative. Due to Dr. Lanckriet's role and the Reporting Person's position as the sole member of the management board of Biofrontera AG, the Reporting Person may be deemed a director by deputization of Biofrontera Inc. The filing discloses that Biofrontera AG holds 400,000 shares of common stock and Series D Convertible Preferred Stock, which is convertible into 4,831,172 shares of common stock. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her indirect pecuniary interest.